{"@type": "dcat:Dataset", "accessLevel": "public", "accrualPeriodicity": "R/P1Y", "bureauCode": ["009:10"], "contactPoint": {"@type": "vcard:Contact", "fn": "Division of Drug Information", "hasEmail": "mailto:druginfo@fda.hhs.gov"}, "description": "This prescription medication combines bismuth subcitrate potassium (140 mg), metronidazole (125 mg), and tetracycline hydrochloride (125 mg) in oral capsules. It's used to treat infections caused by Helicobacter pylori bacteria, often in combination with other therapies for stomach ulcers or gastritis. Take as directed by a doctor. This information was generated using AI and is provided for informational and research purposes only.", "distribution": [{"@type": "dcat:Distribution", "description": "\n        Access the FDA dataset for Bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride \u2014 ANDA 217511 submitted by Mylan Institutional LLC\n    ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217511", "mediaType": "text/html", "title": "Bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride"}], "identifier": "ANDA217511", "issued": "2016-09-16", "keyword": ["drug-manufacturers", "drug-safety", "fda", "pharmaceuticals", "public-health"], "landingPage": "https://www.fda.gov/drugs", "license": "https://open.fda.gov/license", "modified": "2025-03-17", "programCode": ["009:002"], "publisher": {"@type": "org:Organization", "name": "U.S. Food and Drug Administration"}, "theme": ["FDA"], "title": "Bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride"}